IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $26,423,000 | +275.8% | 310,752 | +56.6% | 0.10% | +197.1% |
Q2 2020 | $7,032,000 | +2420.4% | 198,432 | +860.6% | 0.04% | +1650.0% |
Q1 2020 | $279,000 | -77.3% | 20,658 | -67.7% | 0.00% | -60.0% |
Q1 2019 | $1,229,000 | -71.1% | 63,974 | -78.6% | 0.01% | -73.7% |
Q4 2018 | $4,256,000 | +0.5% | 298,249 | +46.8% | 0.02% | +26.7% |
Q3 2018 | $4,233,000 | +49.0% | 203,230 | +69.4% | 0.02% | +25.0% |
Q2 2018 | $2,841,000 | – | 120,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 4,750,000 | $112,433,000 | 20.02% |
Avoro Capital Advisors LLC | 17,714,461 | $419,301,000 | 16.14% |
Foresite Capital Management III, LLC | 2,541,729 | $60,163,000 | 12.96% |
Foresite Capital Management IV, LLC | 1,231,543 | $29,151,000 | 9.94% |
Ghost Tree Capital, LLC | 1,250,000 | $29,588,000 | 8.71% |
NEXTHERA CAPITAL LP | 1,329,104 | $31,460,000 | 4.87% |
RA Capital Management | 3,119,778 | $73,845,000 | 4.79% |
DLD Asset Management, LP | 2,682,100 | $63,458,000 | 4.78% |
Palo Alto Investors LP | 4,803,364 | $113,696,000 | 4.54% |
DLD Asset Management, LP | 2,411,600 | $57,058,000 | 4.30% |